3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
162
Myelodysplastic Syndromes
44
Leukemia, Myelomonocytic, Chronic
26
Leukemia
16
Myeloproliferative Disorders
11
Recurrence
9
Hematologic Neoplasms
8
Neoplasms
6
Lymphoma, T-Cell, Peripheral
6
Primary Myelofibrosis
5
Leukemia, Biphenotypic, Acute
5
Anemia, Refractory, with Excess of Blasts
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasm, Residual
4
Multiple Myeloma
4
Lymphoma, Non-Hodgkin
4
Leukemia, Monocytic, Acute
4
Hematologic Diseases
4
GATA2 Deficiency
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pathologic Complete Response
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Myelodysplastic-Myeloproliferative Diseases
3
Lymphoma
3
Hodgkin Disease
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Polycythemia Vera
2
Lymphoma, T-Cell
2
Interventions
pembrolizumab
12
Pemetrexed
9
Cisplatin
9
Nivolumab
8
Carboplatin
8
Ipilimumab
7
Cyclophosphamide
6
fludarabine
5
durvalumab
4
tremelimumab
2
Radiotherapy, Intensity-Modulated
2
Gemcitabine
2
Cerebral Decortication
2
tocilizumab
1
tislelizumab
1
tazemetostat
1
sotorasib
1
ruxolitinib
1
osimertinib
1
olaparib
1
obinutuzumab
1
naptumomab estafenatox
1
fludarabine phosphate
1
decitabine and cedazuridine drug combination
1
bintrafusp alfa protein, human
1
avelumab
1
atezolizumab
1
Tumor Burden
1
Tablets
1
Saline Solution
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma
×
Azacitidine
×
1 year
×
Clear all
No trials found.